|
|
News Breaks | | | | September 12, 2012 | | 13:55 EDT |  | CYH, CYH, CYH, DVA, DVA, DVA, HCA, HCA, HCA, HMA, HMA, HMA, LPNT, LPNT, LPNT, THC, THC, THC, UHS, UHS, UHS, VHS, VHS, VHS | Leerink's healthcare services analyst holds an analyst/industry conference call
Healthcare Services Analyst Gurda discusses the future of healthcare delivery on an Analyst/Industry conference call. Covered companies CYH, DVA, HCA, HMA, LPNT, THC, UHS and VHS will be included on the Analyst/Industry conference call to be held September 13 at 2 pm. | |
|
News For CYH;DVA;HCA;HMA;LPNT;THC;UHS;VHS From The Last 14 Days Check below for free stories on CYH;DVA;HCA;HMA;LPNT;THC;UHS;VHS the last two weeks. |
|
|
| June 19, 2013 | | 07:57 EDT | | VHS, UHS | Wells Faro to host a conference
 Subscribe for More Information | | | June 18, 2013 | | 09:45 EDT |  | HMA | Health Management buyers worried about issues, CNBC reports
Subscribe for More Information | | | June 17, 2013 | | 10:10 EDT |  | HMA | On The Fly: Analyst Downgrade Summary
Subscribe for More Information | | | 09:19 EDT | | DVA | On The Fly: Pre-market Movers
Subscribe for More Information | | | 08:06 EDT |  | HMA | Health Management price target raised to $16-$24 from $13.50-$16 at Wells Fargo
Wells Fargo increased its price target on Health Management (HMA) to reflect what it thinks would be the upper end of the range that an acquirer of the company would be willing to pay. The firm believes that the stock's recent appreciation indicates that a deal has become more likely, and it keeps an Outperform rating on the shares. | | | 07:07 EDT | | DVA | DaVita, Myriad RMB announces biomarker research collaboration
Subscribe for More Information | | | 06:42 EDT | | HMA | Health Management downgraded to Neutral from Buy at Mizuho
Subscribe for More Information | | | June 14, 2013 | | 11:23 EDT |  | DVA | Options with increasing implied volatility: TWO SRPT LNCO LINE DVA
| | | June 13, 2013 | | 08:46 EDT | | HMA | Health Management could be worth $18-$19 in a buyout, says Susquehanna
Susquehanna noted Health Management engaged financial advisors to help it explore strategic alternatives. The firm believes the company could be worth $18-$19 per share in a buyout but could be worth $12 if no deal is made. Shares are Positive rated with a $16 price target. | | | June 12, 2013 | | 16:43 EDT | | HMA | Health Management engages firms in connection with Glenview disclosure
Subscribe for More Information | | | | 16:20 EDT |  | HMA | On The Fly: Closing Wrap
Stocks on Wall Street were lower despite opening sharply higher as the market looked to avoid its first three day losing streak of the year. Downside momentum quickly took hold however, and the averages moved steadily lower through the session, moving to their lows in the final hour of trading but finishing just off those levels. ECONOMIC EVENTS: In the U.S., the MBA's purchase applications composite index rose 5.0% for the week. The U.S. posted a $139B May budget deficit against expectations for a $130B deficit, and compared to a $124.6B deficit a year ago. In Europe, factory production in the 17-nation euro area rose 0.4% in April from March, compared to expectations for it to remain unchanged. COMPANY NEWS: Cooper Tire (CTB) agreed to be acquired by India's Apollo Tyres for $35.00 per share in cash, or $2.5B. Cooper shares surged $10.10, or 41.12%, to $34.66 to trade near $34.50 following the deal announcement, while peer Goodyear Tire (GT) advanced about 33c, or 2.26%, to $14.93... Live Nation (LYV) shares gained $2.33, or 16.84%, to $16.17 after the company announced it prevailed in an arbitration ruling related to a ticketing license software agreement... MAJOR MOVERS: Among the notable gainers was Ulta Salon (ULTA), up $12.51, or 14.87%, to $96.64 following its quarterly earnings report. Also higher was Health Management (HMA), up $1.58, or 11.34%, to $15.51 after Glenview Capital said in a filing it is seeking to repeal a provision that prevents entities from holding more than 15% of the company's stock and saying it would look to nominate candidates to the company's board. Among noteworthy losers was Biogen (BIIB), down $16.48, or 7.39%, to $206.55 after the stock was downgraded to Neutral from Buy at Citigroup, which cited concerns that EU medical regulators are unlikely to approve the company's multiple sclerosis treatment. Also lower were U.S.-listed shares of Vodafone (VOD), down 71c, or 2.47%, to $28.12 after the company confirmed it approached Kabel Deutschland about a possible deal. INDICES: The Dow was down 126.79, or 0.84%, to 14,995.23; the S&P 500 was down 13.61, or 0.84%, to 1,612.52; the Nasdaq was down 36.52, or 1.06%, to 3,400.43. | | | 10:16 EDT | | CYH, HMA | Health Management rallies after hedge fund seeks to raise stake
Shares of hospital operator Health Management (HMA) are surging after a hedge fund indicated that it wishes to increase its stake in the company to over 15%, and nominate candidates to the company's board. WHAT'S NEW: In a regulatory filing last night, hedge fund Glenview Capital wrote that it was asking Health Management to repeal a "poison pill" provision that prevents any entity from obtaining more than a 15% stake in Health Management. At a minimum, Glenview wants the hospital operator to raise the minimum permitted stake to 25%. Furthermore, the hedge fund, which currently owns a 14.56% stake in HMA, stated that it would look to nominate candidates for Health Management's board. ANALYST REACTION: In a note to investors earlier today, Deutsche Bank analyst Darren Lehrich upgraded Health Management to Buy from Hold. Recent changes in Health Management's top executives, along with Glenview's statements, increase the chances that HMA will look to sell itself, Lehrich indicated. HMA could be worth more than $20 per share if it is sold, the analyst wrote. Meanwhile, the analyst also upgraded another hospital operator, Community Health Systems (CYH) to Buy from Hold. Community Health Systems, in which Glenview has a 10.7% stake, could look to acquire Health Management, the analyst believes. Community Health's profits could increase significantly if it buys Health Management, added the analyst. He raised his price target on Health Management to $18 from $12, and increased his price target on Community Health to $59 from $51. TODAY'S PRICE ACTION: In early trading, Health Management jumped 9% to $15.20, while Community Health advanced 2.7% to $50.30. | | | 10:14 EDT |  | CYH, HMA | On the Fly: Upgrade Summary
Subscribe for More Information | | | 09:07 EDT | | HMA | On The Fly: Pre-market Movers
Subscribe for More Information | | | 09:04 EDT | | HCA | ClearLight Partners to sell The Outsource Group to HCA subsidiary
Subscribe for More Information | | | 06:35 EDT | | HMA | Health Management upgraded to Fair Value from Sell at CRT Capital
CRT Capital upgraded Health Management due to Glenview's activist stake in the company. | | | 05:49 EDT | | HMA, CYH | Health Management upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information | | | 05:46 EDT | | CYH, HMA | Community Health upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank upgraded Community Health (CYH) on expectations Glenview's activist stake in Health Management (HMA) could lead to upside. The firm sees potential for Community Health merging with Health Management given Glenview's cross-ownership of Community Health and the company's appetite for deals. Deutsche raised its price target for Community Health shares to $59 from $51 and also upgraded shares of Health Management. | | | 05:44 EDT | | HMA | Glenview asks Health Management to remove poison pill
Subscribe for More Information | | | June 11, 2013 | | 16:47 EDT | | HMA | Health Management signs letter of intent to lease Munroe Regional Medical Center
Subscribe for More Information | | |
|
|
|
|
|
|
